OBERWEIS ASSET MANAGEMENT INC/ Q4 2017 Filing

Filed February 14, 2018

Portfolio Value

$427.5B

Holdings

234

Report Date

Q4 2017

Filing Type

13F-HR

All Holdings (234 positions)

#StockSharesValue% PortfolioType
201
AXGNAxogen Inc.
11,200$317.0M0.07%
202
IM8NInsmed Incorporated
10,000$312.0M0.07%
203
HANHawaiian Holdings, Inc.
7,800$311.0M0.07%
204
SFStifel Financial Corp.
5,220$311.0M0.07%
205
FNBFNB Corp.
22,380$309.0M0.07%
206
MAMastercard, Inc.
2,008$304.0M0.07%
207
RLGTRadiant Logistics, Inc.
64,585$297.0M0.07%
208
Esterline Technologies Corp.
3,900$291.0M0.07%
209
FLOFlowers Foods, Inc.
15,010$290.0M0.07%
210
AMGNAmgen, Inc.
1,649$287.0M0.07%
211
PAGPenske Automotive Group, Inc.
5,920$283.0M0.07%
212
SIGSignet Jewelers Ltd.
4,925$279.0M0.07%
213
WMTWal Mart Stores Inc.
2,788$275.0M0.06%
214
NHINational Health Investors, Inc
3,550$268.0M0.06%
215
DST Systems, Inc.
4,317$268.0M0.06%
216
BKBank of New York Mellon Corp.
4,833$260.0M0.06%
217
MNSTMonster Beverage Corp.
4,000$253.0M0.06%
218
ARNAEURArena Pharmaceuticals, Inc.
7,300$248.0M0.06%
219
SAICScience Applications Int'l. Co
3,135$240.0M0.06%
220
NEMNewmont Mining
6,237$234.0M0.05%
221
CVVCVD Equipment Corp.
20,000$232.0M0.05%
222
XNCRXencor, Inc.
10,200$224.0M0.05%
223
DowDuPont, Inc.
2,847$203.0M0.05%
224
BACVerizon Communications
3,787$200.0M0.05%
225
Vonage Hldgs Corp
18,300$186.0M0.04%
226
VNDAVanda Pharmaceuticals, Inc.
10,700$163.0M0.04%
227
CEFSprott Physical Gold and Silve
11,800$158.0M0.04%
228
FMFFormfactor Inc.
10,000$157.0M0.04%
229
BCRXBiocryst Pharmaceuticals, Inc.
30,600$150.0M0.04%
230
FEYECHFFireeye,Inc.
10,510$149.0M0.03%
231
Avatar Ventures
10,000$00.00%
232
Xenacare Hldgs, Inc.
140,000$00.00%
233
Tital Oil & Gas, Inc.
10,000$00.00%
234
American Power Corp
10,000$00.00%
PreviousPage 3 of 3